By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Affymetrix reported after the close of the market Wednesday that its fourth-quarter revenues increased 13 percent, driven by a 30 percent increase in sales of its genotyping products.

The Santa Clara, Calif.-based microarray technologies firm reported total revenues of $88.8 million for the three-month period ended Dec. 31, up from $78.6 million for the fourth quarter of 2008. It easily beat analysts' consensus revenue estimate of $82.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: Uncovering variants associated with diabetes-related kidney disease, a sequencing study of hepatitis E viruses circulating in Cambodia, and more.

Among Sacks' books was "Awakenings," which was later made into an Academy Award-winning film.

The popularity of the #sciencemoviequote Twitter trend showcases scientists' eclectic movie tastes and knack for puns. 

In Science this week: issues in reproducibility, circulating DNA predicts breast cancer relapse, and more.